Candel Therapeutics Inc (NASDAQ: CADL) Is The Number One Stock Currently Moving.

Candel Therapeutics Inc (NASDAQ:CADL) price closed lower on Monday, April 15, dropping -12.61% below its previous close.

A look at the daily price movement shows that the last close reads $6.66. The company’s 5Y monthly beta was ticking 0.92. Taking into account the 52-week price action we note that the stock hit a 52-week high of $11.40 and 52-week low of $0.66. The stock added 273.08% on its value in the past month.

Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give CADL a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.

The overview shows that CADL’s price is at present 82.73% off the SMA20 and 161.16% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 65.02, with weekly volatility standing at 23.00%. The indicator jumps to 30.72% when calculated based on the past 30 days. Candel Therapeutics Inc (NASDAQ:CADL)’s beta value is holding at -0.22, while the average true range (ATR) indicator is currently reading 1.12.

An analysis of the Candel Therapeutics Inc (NASDAQ:CADL) stock in terms of its daily trading volume indicates that the 3-month average is 5.26 million.

Current records show that the company has 29.21M in outstanding shares. The insiders’ percentage holdings are 46.65% of outstanding shares while the percentage share held by institutions stands at 5.76%. But the 295.92% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Most Popular